Review Series

Measurable residual disease in chronic myeloid leukemia

Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; School of Medicine, University of Adelaide, Adelaide, Australia; Clinical and Health Sciences, University of South Australia, Adelaide, Australia
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK; Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK
Vol. 107 No. 12 (2022): December, 2022